UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 441

Sortiert nach

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Clinical cancer research, 2021-07, Vol.27 (14), p.3896-3904

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3227-3233

2010

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-01, Vol.22 (1), p.23-30

2004

Link zum Volltext

Verfügbarkeit prüfen

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5721-5727

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3330-3335

2010

Link zum Volltext

Verfügbarkeit prüfen

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials

Journal of clinical oncology, 2008-01, Vol.26 (3), p.463-467

2008

Link zum Volltext

Verfügbarkeit prüfen

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics

Journal of clinical oncology, 2009-07, Vol.27 (21), p.3540-3546

2009

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

BMC cancer, 2023-11, Vol.23 (1), p.1-1056, Article 1056

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

Journal of clinical oncology, 2006-07, Vol.24 (21), p.3347-3353

2006

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors

Cancers, 2023-04, Vol.15 (9), p.2553

2023

Link zum Volltext

Verfügbarkeit prüfen

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

Cancer control, 2023-01, Vol.30, p.10732748231185047-10732748231185047

2023

Link zum Volltext

Verfügbarkeit prüfen

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

Cancers, 2023-05, Vol.15 (11), p.2978

2023

Link zum Volltext

Verfügbarkeit prüfen

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4771-4776

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3542-3547

2006

Link zum Volltext

Verfügbarkeit prüfen

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy

Exploration of targeted anti-tumor therapy, 2023, Vol.4 (3), p.396-405

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9097-9104

2005

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-08, Vol.77 (2), p.252-259

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Tirapazamine, Cisplatin, and Etoposide and Concurrent Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: SWOG 0222

Journal of clinical oncology, 2009-06, Vol.27 (18), p.3014-3019

2009

Link zum Volltext

Verfügbarkeit prüfen

A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer

Frontiers in oncology, 2014-01, Vol.4, p.271-271

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Complete Response to Chemotherapy on Overall Survival in Advanced Colorectal Cancer: Results From Intergroup N9741

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3469-3474

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

Frontiers in oncology, 2016-01, Vol.5, p.301

2016

Link zum Volltext

Verfügbarkeit prüfen

Tirapazamine: a novel agent targeting hypoxic tumor cells

Expert opinion on investigational drugs, 2009-01, Vol.18 (1), p.77-87

2009

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Journal of clinical oncology, 2023-07, Vol.41 (19), p.3461-3468

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies

Cancer chemotherapy and pharmacology, 2015-05, Vol.75 (5), p.1075-1087

2015

Link zum Volltext

Verfügbarkeit prüfen

Leiomyosarcoma of the inferior vena cava: a case report and review of the literature

Cases journal, 2010-02, Vol.3 (1), p.71-71, Article 71

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 441

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(403)
Mit Volltextzugriff
(405)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(440)
Japanisch
(61)

Erscheinungsjahr

n.n

Thema

Science & Technology
(293)
Life Sciences & Biomedicine
(263)
Humans
(239)
Female
(157)
Male
(151)
Aged
(95)
Middle Aged
(94)
Biological And Medical Sciences
(81)
Medical Sciences
(69)
Adult
(68)
Oncology
(66)
Aged, 80 And Over
(44)
Treatment Outcome
(35)
Social Sciences
(34)
Animals
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(30)
General & Internal Medicine
(30)
Medicine, General & Internal
(29)
Clinical Trials
(27)
Risk Factors
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics

Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study

Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy

Phase III Trial of Paclitaxel Plus Carboplatin With or Without Tirapazamine in Advanced Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S0003

Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer

Phase II Study of Tirapazamine, Cisplatin, and Etoposide and Concurrent Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: SWOG 0222

A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer

Impact of Complete Response to Chemotherapy on Overall Survival in Advanced Colorectal Cancer: Results From Intergroup N9741

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

Tirapazamine: a novel agent targeting hypoxic tumor cells

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies

Leiomyosarcoma of the inferior vena cava: a case report and review of the literature

Suchergebnisse filtern